Vimarsana
Biggest News Aggregation in the World

Page 6 - Anders Rylander News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Anders Rylander. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Anders Rylander Today - Breaking & Trending Today

Biovica International: Biovica establishes DiviTum TKa Commercialization Partnership in Italy - Vimarsana News

Biovica International: Biovica establishes DiviTum TKa Commercialization Partnership in Italy

UPPSALA, SE / ACCESSWIRE / April 4, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership

Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch ... - Vimarsana News

Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch ...

Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch ...

Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch and Polish Markets - Vimarsana News

Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch and Polish Markets

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the...

Biovica International: Biovica signs DiviTum TKa Commercial Partner Agreement for Dutch and Polish Markets - Vimarsana News

Biovica International: Biovica signs DiviTum TKa Commercial Partner Agreement for Dutch and Polish Markets

UPPSALA, SWEDEN / ACCESSWIRE / March 28, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial

Biovica International: DiviTum TKa Clinical Validation Data Published in Biomarkers - Vimarsana News

Biovica International: DiviTum TKa Clinical Validation Data Published in Biomarkers

UPPSALA, SE / ACCESSWIRE / January 31, 2023 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer diagnostics, today announces that results clinically validating the